본문바로가기
Q
U
I
C
K

PR

SK bioscience company news updates

Media Zoom

SK bioscience acquires approval for typhoid conjugate vaccine

2022.05.17


 

South Korea-based SK Bioscience has secured another approval for in-house vaccine.

 

SK Bioscience obtained an export license for the typhoid vaccine ´Skytyphoid Multi-Zoo (task name NBP618, hereafter referred to as Skytyphoid)´ jointly developed with IVI (International Vaccine Institute) for domestic food and drug safety.